Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Pascale Cornillet et al.|Blood|2013Cited by 357
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al.|Blood|2009Cited by 270
Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profilingPascale May‐Panloup, Philippe Guardiola|Human Reproduction|2012Cited by 48